Keeping Current

  • Author: Vários
  • Narrator: Vários
  • Publisher: Podcast
  • Duration: 299:30:30
  • More information

Informações:

Synopsis

Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.

Episodes

  • Biosimilars in Multiple Sclerosis: Entering a New Era of Biologic Therapy

    30/03/2023 Duration: 37min

    Did you know what the inherent variability of all biologics and what degree of variation are acceptable by regulatory bodies?  Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989395?src=mkm_podcast_addon_989395  

  • Are We Ready for Biosimilars in Multiple Sclerosis? Experts Discuss Lessons From Other Immune-Mediated Diseases

    29/03/2023 Duration: 34min

    What is the clinical use of biosimilars and how to best communicate with patients to avoid the nocebo effect?  Credit available for this activity expires: 3/29/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990193?ecd=bdc_podcast_libsyn_mscpedu

  • Global Perspectives on Anti-Vascular Endothelial Growth Factor: If, When, and How to Switch

    29/03/2023 Duration: 01h01min

    Do you reload when switching? What intervals do you extend by? How long is feasible between treatments, and how do you monitor? Learn from the experts.    Credit available for this activity expires: 28/03/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990120?ecd=bdc_podcast_libsyn_mscpedu

  • Clinical Trials in Focus: Durability of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies

    28/03/2023 Duration: 34min

    Do you know how study designs influence the data with anti-vascular endothelial growth factor (anti-VEGF) therapies? Find out more.  Earn Credit / Learning Objectives & Disclosures:  https://www.medscape.org/viewarticle/[ArticleID]?src=mkm_podcast_addon_989801  

  • Safeguarding the CKD Patient With or Without Diabetes in Primary Care: Quick Questions, Rapid Replies

    27/03/2023 Duration: 17min

    Did you know that SGLT2 blockade can reduce progression to ESKD by at least a decade in patients with mild-to-moderately decreased eGFR? Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990093?ecd=bdc_podcast_libsyn_mscpedu

  • Optimizing Treatments in Advanced Systemic Mastocytosis With Associated Hematological Neoplasm

    27/03/2023 Duration: 36min

    Do you know which you should be treating first -- the systemic mastocytosis (SM) or the associated hematological neoplasm (AHN)?    Credit available for this activity expires: 3/24/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990024?ecd=bdc_podcast_libsyn_mscpedu

  • Diabetes Dialogue Part 2: Who Are Candidates for GLP-1 Receptor Agonist Therapy in Primary Care?

    24/03/2023 Duration: 18min

    Who should be taking a glucagon-like peptide-1 (GLP-1) receptor agonist (RA)? Join Drs Bain and Lin to find out. Credit available for this activity expires: 3/23/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989998?ecd=bdc_podcast_libsyn_mscpedu

  • Challenging the Harmful Myths About ASCVD Management: The Experts Set the Record Straight

    23/03/2023 Duration: 21min

    Do you know the latest information about dyslipidemia and atherosclerotic cardiovascular disease (ASCVD) risk? Drs Navar and Ray discuss.    Credit available for this activity expires: 03/21/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[989864]?ecd=bdc_podcast_libsyn_mscpedu

  • What Is the Expert Accord on Identifying and Protecting the Patient at Early Stage of CKD?

    16/03/2023 Duration: 37min

    Did you know that early diabetic kidney disease may reduce the life expectancy of patients by 16 years? Credit available for this activity expires: 3/14/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989288?ecd=bdc_podcast_libsyn_mscpedu

  • Optimizing Adjuvant Treatment of Early Breast Cancer: Where Are We Today?

    16/03/2023 Duration: 27min

    PARP inhibitors, CDK4/6 inhibitors, immunotherapy, and SERDS: Can you select optimal treatments for early breast cancer (EBC)? And what might be the consensus at St. Gallen?    Credit available for this activity expires: 03/15/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989483?ecd=bdc_podcast_libsyn_mscpedu

  • Pros and Cons of COVID-19 Vaccination in Children: Weighing the Evidence

    02/03/2023 Duration: 38min

    Are you up to date on COVID-19 vaccination in children?    Credit available for this activity expires: 01/03/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/988590?ecd=bdc_podcast_libsyn_mscpedu  

  • The Road to Safety: Understanding the Common and Less Common Side Effects of COVID-19 and Other Vaccines

    28/02/2023 Duration: 38min

    Do you know what are common and less common adverse events (AEs) following immunization? Credit available for this activity expires: 02/27/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/988364?ecd=bdc_podcast_libsyn_mscpedu

  • Recovering Immune Responses in Heavily Treatment-Experienced HIV-Positive Individuals

    14/02/2023 Duration: 16min

    ​​This educational activity is intended for an international audience of non-US HIV physicians, infectious disease (ID) physicians, and primary care providers (PCPs).​ Credit available for this activity expires: 2/13/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987954?src=mkm_podcast_addon_987954

  • COVID-19 Immunization in Oncology and Stem Cell Transplant Settings: Experts Provide Practical Guidance

    13/02/2023 Duration: 33min

    Did you know that many patients with malignancy have insufficient benefit from 2 doses of COVID-19 vaccines? Join this discussion and see how their outcomes can be improved. Learning Objectives & Disclosures:  https://www.medscape.org/viewarticle/987844?src=mkm_podcast_addon_987844

  • Chronic Kidney Disease – Looking Beyond Diabetes: Expert Interpretation of Latest Evidence From Kidney Outcome Trials

    08/02/2023 Duration: 15min

    How often should you be monitoring kidney function in a patient with an estimated glomerular filtration rate (eGFR) of 50 mL/min/1.73 m2 and a urine albumin-to-creatinine ratio (UACR) above 30 mg/g?  Credit available for this activity expires: 2/7/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987836?src=mkm_podcast_addon_987836  

  • Dengue Immunization: Special Populations

    03/02/2023 Duration: 33min

    Do you know how dengue vaccines can protect special populations and be used during outbreaks? Credit available for this activity expires: 02/01/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987640?ecd=bdc_podcast_libsyn_mscpedu

  • Evolving Hesitancies and Objections to COVID-19 Booster Shots: Separating Facts From Fiction

    31/01/2023 Duration: 40min

    Are you prepared to address your patients’ hesitancy and misinformation about COVID-19 booster shots? Credit available for this activity expires: 01/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987018?ecd=bdc_podcast_libsyn_mscpedu

  • Recent Updates in HR-Positive/HER2-Negative Early Breast Cancer: A Deep Dive Into Understanding the Data and Their Implications

    31/01/2023 Duration: 33min

    Will the newly reported monarchE data change your clinical practice for patients with HR+/HER- early breast cancer? Credit available for this activity expires: 1/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987087?src=mkm_podcast_addon_987087

  • Early-Stage Resectable Non-Small Cell Lung Cancer: Navigating a Changing Treatment Landscape

    26/01/2023 Duration: 36min

    Did you know that there are now promising perioperative immunotherapies available for your patients with early-stage NSCLC? Credit available for this activity expires: 01/24/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987316?ecd=bdc_podcast_libsyn_mscpedu

  • Advanced Age-Related Macular Degeneration: How to Use Imaging to Screen and Monitor Patients

    23/01/2023 Duration: 34min

    A quarter of people aged over 60 have early or intermediate age-related macular degeneration (AMD). Do you know how to assess these patients and determine follow-up schedules? Credit available for this activity expires: 01/19/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987083?ecd=bdc_podcast_libsyn_mscpedu

page 10 from 28